Appeal Nos. 85-2779, 85-2812.United States Court of Appeals, Federal Circuit.
December 5, 1986.
Page 1566
[EDITORS’ NOTE: THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]Page 1567
Henry C. Fuller, Fuller House Hohenfeldt, S.C., Milwaukee, Wis., argued for appellant/cross-appellee. With him on brief was Daniel J. Sammon, Watts, Hoffmann, Fisher Heinke Co., L.P.A., Cleveland, Ohio, of counsel.
Charles B. Lyon, Renner, Otto, Boissellee Lyon, Cleveland, Ohio, argued for appellees/cross-appellants. With him on brief was Gordon D. Kinder.
Appeal from the United States District Court for the Northern District of Ohio.
Before MARKEY, Chief Judge, NEWMAN, Circuit Judge, and SWYGERT, Senior Circuit Judge.[*]
MARKEY, Chief Judge.
[1] Appeal and cross-appeal from a judgment of the United States District Court for the Northern District of Ohio, Civil Action No. C81-130. In Appeal No. 85-2779, Orthokinetics, Inc. (Orthokinetics) appeals from orders: (1) granting a judgment notwithstanding the verdict (JNOV) holding that: (a) claims 5 and 6 of its U.S. Patent No. 3,815,586 (‘586 patent) are invalid under 35 U.S.C. § 102(b) and § 103; (b) claims 1-5 of its U.S. Patent Re. 30,867 (‘867 patent) are invalid under 35 U.S.C. § 103Page 1568
[3] BACKGROUND [4] I. The Claimed Inventions
[5] Orthokinetics manufactures products for invalids and handicapped individuals, including pediatric wheelchairs. It is the assignee of the ‘586 patent issued to Raymond A. Kazik (Kazik) on June 11, 1974, entitled “Orthopedic Chair With Scoliosis Pads” and of the ‘867 patent reissued to Edward J. Gaffney (Gaffney) on February 16, 1982, entitled “Travel Chair”.
[7] On January 26, 1981, Orthokinetics sued, alleging infringement of claims 5 and 6 of the nine claims in the ‘586 patent. On December 31, 1977, it had disclaimed claims 1 through 4. Because claims 5 and 6 depend from claims 1 and 2, however, they contain all of the limitations of claims 1 and 2. [8] The ‘867 reissue patent discloses a collapsible pediatric wheelchair which facilitates the placing of wheelchair-bound persons, particularly children, in and out of an automobile. Orthokinetics asserted infringement of claims 1 through 5 by Safety. Claim 1 reads [underscoring indicates language added by reissue]:1. In a chair having a seat, a back, and means for supporting the same, the improvement comprising a pair of scoliosis pads each adapted to bear against the sides of a human body, and means for mounting said pads adjacent to opposite side of said chair in such position as to provide therapeutic contact with opposite sides of a person seated in said chair for treatment of curvature of the spine.
2. The improvement defined in claim 1 wherein said mounting means for each pad is vertically adjustable to permit said pads to be positioned in a vertically staggered relationship to develop a therapeutic force couple across said person’s trunk tending to straighten out said curvature of the spine.
5. The improvement of claim 2 in combination with a head restraint which coacts with the scoliosis pads to exert therapeutic pressure on the spine.
6. The improvement of claim 5 in which said head restraint comprises pads which embrace the head and means for adjustably positioning said pads with respect to said back.
[9] Claim 2 eliminates the language added by reissue in claim 1 and adds:1. In a wheel chair having a seat portion, a front leg portion, and a rear wheel assembly, the improvement wherein said front leg portion is so dimensioned as to be insertable through the space between the doorframe of an automobile and one of the seats thereof whereby said front leg is placed in support relation to the automobile and will support the seat portion from the automobile in the course of subsequent movement of the wheel chair into the automobile, and the retractor means for assisting the attendant in retracting said rear wheel assembly upwardly independently of any change in the position of the front leg portion with respect to the seat portion while the front leg portion is supported on the automobile and to a position which clears the space beneath the rear end of the chair and permits the chair seat portion and retracted rear wheel assembly to be swung over and set upon said automobile seat.
[10] Claim 3 limits the rear wheel frame of claim 2 to one which “comprises an upwardly arched undercarriage extending between said chair frame and rear wheels.” Claim 4 limits the arch of the undercarriage of claim 3 to one which “substantially matches the angle between said seat portion and said front leg portion whereby said undercarriage swings into close proximity to said leg portion and seat portion when said rear wheel assembly is retracted.” Claim 5 limits the chair frame of claim 3 to one which “comprises spaced support tubes, said upwardly arched undercarriage fitting between said tubes when the undercarriage is retracted.” All five claims asserted are independent claims.wherein said wheel chair has a chair frame including back portion extending upwardly from said seat portion and a front leg portion extending downwardly from said seat portion and wherein said rear wheel assembly includes a rear wheel frame that extends forwardly from said rear wheels and wherein said means for retracting said rear wheel assembly includes means pivotally connecting the front of said rear wheel frame to
Page 1569
said chair frame, and a retractable strut connecting between said rear wheel assembly and said chair frame to support the wheel chair on the rear wheel assembly and to retract the rear wheel assembly upwardly under the chair seat portion by swinging said rear wheel frame upwardly.
[11] II. Procedural History
[12] Orthokinetics introduced the Travel Chair to the market in November of 1973. In 1978, Safety Travel Chairs, Inc. (STC) began to sell similar chairs manufactured by Entron, Inc. (Entron). William J. Pivacek, Clark Chipman, and William J. Cole established STC and were the stockholders and officers of STC and Entron. When Orthokinetics sued STC, Entron, Pivacek, Chipman, and Cole, it alleged willful infringement of claims 5 and 6 of the ‘586 patent and various claims of its then U.S. Patent No. 3,891,229 (‘229 patent). When the ‘229 patent reissued as the ‘867 patent on February 16, 1982, Orthokinetics amended its complaint to allege infringement of claims 1-5 of that patent, and demanded a jury trial. Safety answered that the patents were invalid and not infringed, and counterclaimed that Orthokinetics had misused its patents when it filed its complaint.
Page 1570
[17] III. Summary of the District Court’s Opinion
[18] On June 14, 1985, the district court filed a 69-page unpublished opinion, vacated its January 30 and July 17, 1984 judgments, and dismissed the complaint and counterclaim. It granted Safety’s JNOV motion on validity, holding claims 5 and 6 of the ‘586 patent invalid because the claimed inventions were: (1) on sale or in public use, under § 102(b); and (2) described in a printed publication under § 102(b); and (3) obvious under § 103. The district court held claims 1-5 of the ‘867 patent invalid as: (1) indefinite under § 112; and (2) drawn to inventions that would have been obvious under § 103.
[23] ISSUES
[24] (1) Whether the district court erred in granting Safety’s motion for JNOV on validity of the ‘586 and ‘867 patents.
[30] OPINION [31] (1) Safety’s Motion for JNOV on Validity [32] A. Introduction
[33] This appeal presents an uncommon and somewhat incongruous situation. The district court entered JNOV on validity in favor of the party who had the burden at trial to prove facts by clear and convincing evidence that would require a conclusion of obviousness. 35 U.S.C. § 282; see, e.g., Connell v. Sears, Roebuck Co., 722 F.2d 1542, 1550, 220 USPQ 193, 199-200 (Fed. Cir. 1983); Moore v. Shultz, 491 F.2d 294, 298-99, 180 USPQ 548, 551 (10th Cir.), cert. denied, 419 U.S. 930, 95 S.Ct. 203, 42 L.Ed.2d 161 (1974). Under the law set by Congress, a jury or a court may reach a conclusion that a patent remains valid solely
on the failure of the patent challenger’s evidence to convincingly establish the contrary. A patent being presumed valid at birth, § 282, a patentee need submit no evidence in support of a conclusion of validity by a court or a jury. If the patent challenger introduces evidence that might lead to a conclusion of invalidity, a patentee would be well advised to introduce evidence sufficient to rebut that of the challenger. If the challenger’s evidence be totally inadequate, a patentee’s motion for judgment or directed verdict that the challenger’s § 282 burden had not been carried would be appropriately granted before the patentee introduces any rebuttal evidence.
Page 1571
which a statute or case law has assigned burdens of proof. Courts can hardly be criticized for confusing the burden assignment when counsel proceed as though the statute, § 282, did not exist.
[35] As here, patentees have historically sought to “go first” with testimony on validity, on the empirically unproven premise that a favorable “first impression” of the merits of the invention will carry through to victory. Courts and alleged infringers have acquiesced in the practice. The resulting erroneous but clear impression that patentees bear a burden of “proving validity” has frequently resulted in cluttered records, irrelevant detours, undue burdens on the judicial process, and unnecessary work for the trial court. [36] Recognizing that trials conducted in accord with the statutorily assigned burdens would not result in assured victory or more victories for either side, courts should consider pretrial orders designed to facilitate such trials. [37] Similarly, courts should consider pretrial orders in jury trials that specify precisely what the jury will be asked to do after it has been given instructions prepared in light of the evidence and at the end of its deliberations: (1) return a general verdict (“we find for plaintiff/defendant”); (2) return a general verdict accompanied by answers to factual interrogatories prepared in light of the evidence; (3) return special verdicts on specific issues appearing in the evidence (“we find for plaintiff/defendant on the XXXXXXX issue”; or (4) merely “advise.” Unfortunately, as counsel stated at oral argument, that was not done here.[38] B. Standard of Review
[39] This court has recently reiterated the standard under Fed.R.Civ.P. 50(b) concerning a motion for JNOV in relation to an issue on which the movant did not have the burden of proof:
[40] DMI, Inc. v. Deere Co., 802 F.2d 421, 425, 231 USPQ 276, 278 (Fed. Cir. 1986); see Weinar v. Rollform Inc., 744 F.2d 797, 805, 223 USPQ 369, 373 (Fed. Cir. 1984), cert. denied, 470 U.S. 1084, 105 S.Ct. 1844, 85 L.Ed.2d 143 (1985). If then the district court is “convinced upon the record before the jury that reasonable persons could not reach or could not have reached a verdict for the non-mover, it should grant the motion for directed verdict or for JNOV.” Connell, 722 F.2d at 1546, 220 USPQ at 197; see Quaker City Gear Works, Inc. v. Skil Corp., 747 F.2d 1446, 1454-55, 223 USPQ 1161, 1166-67 (Fed. Cir. 1984), cert. denied, 471 U.S. 1136, 105 S.Ct. 2676, 86 L.Ed.2d 694 (1985). [41] To convince this court that a trial judge erred in granting a motion for JNOV, an appellant need only show that there was substantial evidence to support the jury’s findings and that those findings can support the jury’s legal conclusion Shatterproof Glass Corp. v. Libbey-Owens Ford Co., 758 F.2d 613, 619, 225 USPQ 634, 636 (Fed. Cir.), cert. dismissed,A trial judge presented with a motion for JNOV (1) must consider all the evidence in a light most favorable to the non-mover, (2) must not determine credibility of witnesses, and (3) must not substitute his or her choice for the jury’s in finding facts, drawing inferences, or deciding between conflicting elements in the evidence.
Page 1572
[43] C. The ‘586 patent[44] (i) On Sale/Public Use, § 102(b)
[45] The jury specifically found (question No. 31) that Safety failed to prove by clear and convincing evidence that the “subject matter” of claims 5 and 6 of the ‘586 patent was offered for sale or publicly used more than one year before its December 4, 1972 filing date. Because of that finding, the jury had no reason to, and did not answer the interrogatory on whether Orthokinetics had proved that what Safety alleged was a sale offer/public use was in fact done for an experimental purpose. The district court held that the jury’s finding of no offer for sale or public use was “without basis in the record.”
Page 1573
35 U.S.C. § 282, and the jury had the right to reject its
evidence as insufficient to carry that burden. Under those circumstances, this court may determine only whether the evidence the jury could have believed in making its critical findings was substantial. Because a jury must by definition be permitted to accept some probative evidence and reject other probative evidence, we may not decide whether we would as jurors have found Orthokinetics’ evidence, in Safety’s words, “believable in light of the evidence as a whole.” This is not a case in which there was no evidence in support of a jury’s finding, or one in which the only evidence relating to a finding was contrary to that finding. See Connell v. Sears, Roebuck Co., 722 F.2d 1542, 1550, 220 USPQ 193, 200 (Fed. Cir. 1983) (“the jury finding that there was `no prior art’ could not possibly stand in the face of the numerous clearly relevant prior art patents in the trial record”).
Page 1574
testimony must be drawn adversely to Safety.
[57] (ii) Printed PublicationPage 1575
items picked from the references as later done by the district court, would not have produced the claimed inventions or would not have been obvious when the invention was made. No basis or reason exists in the record for the district court to have substituted its contrary conclusion. The jury heard the testimony of Safety’s own witness, Professor Cherry, who testified on the improvements contributed in the ‘586 patent. Those improvements did not consist of a mere combining of a “head rest” with Kinney’s scoliosis system; they contributed a coaction between the pads and a head restraint to provide therapeutic pressure at three points. Moreover, that the claims do not contain the phrase “three-point positioning” is not material, the coaction between the pads being effective to produce that result. See In re Antonie, 559 F.2d 618, 619, 195 USPQ 6, 8 (CCPA 1977) (claims need not recite inherent advantages relied on for patentability).
[66] Moreover, the district court’s analysis employed an inappropriate “would have been able to produce” test. The statute, § 103, requires much more, i.e., that it would have bee obvious to produce the claimed invention at the time it was made without the benefit of hindsight. [67] The jury also found (question Nos. 34-37) that Orthokinetics had proved by a preponderance of the evidence that certain objective indicia support the validity of the ‘586 patent, i.e., unsuccessful attempts by others, long felt need, and commercial success. Though the district court viewed those jury findings as “without factual foundation,” the record reflects substantial evidence on which a reasonable jury could have made each of those findings. [68] Because the district court erred in setting aside the jury’s verdict that the inventions set forth in claims 5 and 6 would not have been obvious, the grant of Safety’s motion for JNOV on the validity of the ‘586 patent must be reversed.[69] D. The ‘867 Patent[70] (i) Indefiniteness
[71] The jury found (question No. 51) that Safety failed to prove by clear and convincing evidence that the ‘867 patent was invalid because of claim language that does not particularly point out and distinctly claim the invention. 35 U.S.C. § 112, 2d ¶. The district court determined otherwise and granted Safety’s motion for JNOV.
[74] The foregoing statement employs two measures impermissible in law: (1) it requires that claim 1 “describe” the invention, which is the role of the disclosure portion of the specification, not the role of the claims; and (2) it applied the “full, clear, concise, and exact” requirement of the first paragraph of § 112 to the claim, when that paragraph applies only to the disclosure portion of the specification, not to the claims. Standard Oil Co. v. American Cyanamid Co., 774 F.2d 448, 453, 227In response to this testimony, which clearly and convincingly establishes that claim 1 of the [‘867] patent does not describe the invention in “full, clear, concise and exact terms,” Orthokinetics points only to the conclusory statements of Hobbs, Gaffney and expert witness William McCoy, Jr., that the patent is, in fact definite. These conclusory statements are not an adequate basis for the jury to reject Safety’s defense. The undisputed, specific testimony of Gaffney and Hobbs demonstrates that an individual desiring to build a non-infringing travel chair cannot tell whether that chair violates the [‘867] patent until he constructs a model and tests the model on vehicles ranging from a Honda Civic to a Lincoln Continental to a Checker cab. Without those cars, “so dimensioned” is without meaning.
Page 1576
USPQ 293, 297 (Fed. Cir. 1985). The district court spoke, inappropriately, of indefiniteness of the “patent,” and did not review the claim for indefiniteness under the second
paragraph of § 112.
[82] The district court quoted the language added by reissue in claims 2-5, supra, and focused on the differences between the reissued ‘867 claims and those of the original ‘229 patent. Claims 3-5 were also characterized as adding “minor details.” [83] It is not altogether clear from the passage quoted above whether the district court was comparing the claims of the ‘867 patent with Allen or with the original patent.Analysis begins with Gaffney’s concession to the [U.S. Patent and Trademark Office] that [U.S. Patent No. 1,693,633 issued to Sarah Allen (Allen)] fully anticipated the original Gaffney patent, rendering that patent void under § 102. Therefore, the only novel aspects of the reissue patent [i.e. the ‘867 patent] claims are those portions of such claims which differ from the language of the original patent. Claim 1 added to original Claim 1 a “retractor means for assisting the attendant in retracting said rear wheel assembly . . . while the front leg is supported on the automobile. . . .”
Page 1577
A careful reading of the district court’s opinion, and its amendments, however, makes clear that the claims of the original patent were applied as prior art against the ‘867 patent. That was legal error for the reasons discussed in Interconnect Planning Corp. v. Feil, 774 F.2d 1132, 1137, 227 USPQ 543, 546-47 (Fed. Cir. 1985), and Safety’s attempt to distinguish that case is unpersuasive.
[84] If the district court compared the ‘867 claims with the Allen patent, that comparison was based on an erroneous presumption, i.e., that Gaffney made a “concession” that Allen anticipated the claims of the original patent. Gaffney’s reissue oath stated only that he believed “the original patent to be wholly or partly inoperative or invalid because claims 1 and 11 are unpatentable over [Allen].” 35 U.S.C. § 251; see 37 C.F.R. § 1.175(1) (1985); Manual of Patent Examining Procedure 1414 (5th ed. 1983). That is not, as Safety calls it, a “binding admission” of anticipation. In fact, even a cursory review of the Allen patent shows on its face that the jury could readily have found that it does not disclose each element of Gaffney’s original patent. [85] The district court stated (underscoring indicates amendments adding to the court’s original opinion; brackets indicate amendments deleting from the court’s original opinion):[86] The district court’s amendment changing “the differences are obvious” to “the claimed invention as a whole would have been obvious to one of ordinary skill at the time of the invention” substituted the correct statutory criteria, § 103, for the unauthorized “differences are obvious” standard. Despite that change, however, it is clear from the entire record and from a study of the amended opinion in its entirety, that the court substituted its view for that of the jury on the basis of its belief that the presence of individual elements in separate prior patents required a conclusion of obviousness. [87] The court concluded that (emphasis added):Given the jury’s findings with respect to the level of ordinary skill in the art, the proper scope and content of the prior art and its details as summarized above, and assuming that the jury’s general verdict constitutes a sufficient finding concerning the differences between the prior art and the Gaffney reissue patent claims, the question for this Court is whether any reasonable basis existed for [finding those differences] their finding. On consideration, it is eminently clear that no such basis exists — that is, that all the differences between claims 1 through 5 of the Gaffney reissue patent [are] and the prior art are such that the claimed invention as a whole would have been obvious in light of the prior art to one of ordinary skill in the art at the time of the Gaffney invention.
[Footnotes omitted.]
[88] As it did in respect of the ‘586 patent, the court applied its “able to produce” standard in place of the statutory “obvious” standard of § 103. There was probative evidence in support of the jury’s conclusion (testimony of Hobbs, Gaffney, Kazik, Inouye, Pivacek). Neither the court nor any witness identified what in the references suggested their combination or what in the references would produce the results of the claimed inventions.clear and convincing evidence demonstrates that in 1972 the holder of a college degree in engineering with experience in the wheel chair fields, presented with the Allen patents and the other patents described above, would doubtless have been able to produce the structure defined in claims 1 through 5 of the Gaffney reissue patent; no probative evidence to the contrary was presented to the jury. The prior art suggests the combination both expressly and by implication, and no original new patent’s result is achieved which is not suggested by the combinations. Applying the Railroad Dynamics test, this Court concludes that the jury’s implied conclusion that there were differences between the prior art and the claims in issue is unsupported by substantial evidence.
Page 1578
[89] It is unclear whether the district court believed there wer no differences between the claimed inventions of the ‘867 patent and the prior art. Though the court listed no differences, it is undisputed that there are at least there differences: the combination of legs as lever for loading the chair into an automobile and the retraction of the rear wheels by the attendant while the patient remains in the chair. The sole question, therefore, is whether that difference, which we must presume was found by the jury, constituted substantial evidence in support of its nonobvious conclusion. [90] A review of each of the five prior art references establishes unequivocally that there was substantial evidence in support of the jury’s implied findings of those differences. That evidence plus the objective evidence of nonobviousness (commercial success, failure of others, long felt need) supply a fully adequate basis on which a reasonable juror could have concluded that the subject matter as a whole of the inventions claimed in the ‘867 patent would not have been obvious to one of ordinary skill in the art. Neither the record nor the district court’s opinion provides a basis for the substitution of a conclusion to the contrary. Therefore, the district court’s setting aside of the jury’s verdict upholding claims 1-5 of the ‘867 patent must be reversed.[91] (2) Infringement
[92] The jury found (question Nos. 1-4) that Orthokinetics had met its burden of proving by a preponderance of the evidence that the accused chairs constituted infringement of claims 5 and 6 of the ‘586 patent. The testimony of Gaffney and Inouye, which supports that finding, faced no cross-examination and went unrebutted by Safety. The district court correctly denied Safety’s motion for JNOV on infringement of the `586 patent.
[96] (3) Personal Liability for Infringement
[97] The jury found (question Nos. 5-10, 18-23) that Chipman, Cole and Pivacek were personally liable for acts of direct infringement and for inducing infringement of both patents.
Page 1579
actively aid and abet their corporation’s infringement may be personally liable for inducing infringement under § 271(b) regardless of whether the corporation is the alter ego of the corporate officer. Power Lift, Inc. v. Lang Tools, Inc., 774 F.2d 478, 481, 227 USPQ 435, 437 (Fed. Cir. 1985).
[100] Corporate officers are presumably aware of what they are doing, and in that sense they can be said to have acted “willfully.” However, that does not mean that their acts must rise to the level recognized by the law as constituting willful infringement before they can be liable for infringement by their corporation. Hence the district court erred in positing willful infringement as a prerequisite for the imposition of personal liability for the corporation’s direct infringement. [101] To determine whether corporate officers are personally liable for the direct infringement of the corporation under § 271(a) requires invocation of those general principles relating to piercing the corporate veil. [102] Infringement is a tort, Carbice Corp. v. American Patents Development Corp., 283 U.S. 27, 33, 51 S.Ct. 334, 336, 75 L.Ed. 819, 8 USPQ 211, 213 (1931), and officers of a corporation are personally liable for tortious conduct of the corporation if they personally took part in the commission of the tort or specifically directed other officers, agents, or employees of the corporation to commit the tortious act. See generally 3A W. Fletcher, Cyclopedia of the Law of Private Corporations § 1135 (rev. perm. ed. 1975). The cases are legion in which courts have recognized and imposed personal liability on corporate officers for participating in, inducing, and approving acts of patent infringement. See, e.g., White v. Mar-Bel, Inc., 509 F.2d 287, 185 USPQ 129 (5th Cir. 1975); Rex Chainbelt, Inc. v. General Kinematics Corp., 363 F.2d 336, 150 USPQ 319 (7th Cir. 1966) see generally D. Chisum, Patents, § 16.06, at 16-76 to 16-85 (1986). [103] The evidence established the makeup and control of STC and Entron. Pivacek testified that he was at all material times the President and sole stockholder of Entron and that he elected its Board of Directors. He also testified that he is the President of STC and that he, Cole, and Chipman held all of STC’s directorships and owned all of the stock in STC. The evidence firmly establishes that Pivacek, Cole and Chipman were directly responsible for the design and production of the infringing chairs and that they were the only ones who stood to benefit from sales of those chairs. That evidence was fully sufficient to support the jury’s imposition of personal liability on Pivacek, Cole, and Chipman for the direct infringement of STC and Entron and for STC’s contributory infringement. The district court’s setting aside of the jury’s findings on personal liability must therefore be reversed.[104] (4) Willful Infringement of the ‘867 Patent
[105] Fed.R.Civ.P. 50(a) states that a “motion for a directed verdict shall state the specific grounds therefor.” Rule 50(b) states that “a party who has moved for a directed verdict may move to have the verdict and any judgment entered thereon set aside and to have judgment entered in accordance with his motion for a directed verdict.” A specific reference to an issue in a motion for JNOV cannot preserve that issue for appeal where that issue was not specifically included in a motion for directed verdict made before the jury retired to consider its verdict. See, e.g., Kinzenbaw v. Deere Co., 741 F.2d 383, 387, 222 USPQ 929, 931 (Fed. Cir. 1984), cert. denied, 470 U.S. 1004, 105 S.Ct. 1357, 84 L.Ed.2d 379 (1985).
Page 1580
for directed verdict because Orthokinetics never objected to its inclusion in Safety’s motion for JNOV before the district court.
[108] Orthokinetics’ reliance here on a page in its brief on the motion is insufficient because that page is not of record before us. Moreover, Orthokinetics’ oral statements to the district court indicate that it never intended to contest the inclusion of the issue of willfulness in Safety’s JNOV motion. Though the district court might well have refused consideration of willfulness on the motion for JNOV in light of Rule 50(b), it did not. In view of Orthokinetics’ failure to raise an objection before the district court, we will consider the issue. Cox v. City of Freeman, Missouri, 321 F.2d 887, 891 (8th Cir. 1963). [109] The district court determined that, because Safety was told by a dealer of a district court’s ruling in another case that the original ‘229 patent was invalid, (Palmer v. Orthokinetics, Inc., 197 USPQ 207 (C.D.Cal. 1977), rev’d, 611 F.2d 316, 204 USPQ 893 (9th Cir. 1980)), no reasonable and fair minded juror could have found willful infringement, and set aside the jury’s findings that STC, Entron, Cole, and Chipman willfully infringed the ‘867 patent. [110] A finding of willful infringement is based on a totality of the circumstances. See, e.g., Kloster Speedsteel AB v. Crucible Inc., 793 F.2d 1565, 1579-80, 230 USPQ 81, 90-91 (Fed. Cir. 1986) and cases cited therein. It is not necessary to determine which combination of facts, among those established by substantial evidence at trial and recognized by this court as capable of contributing to a willfulness finding, were relied upon by the jury. This court, and the district court on the motion for JNOV, must uphold the jury determination of willfulness if there is any set of facts supported by substantial evidence and capable of supporting that jury determination. See, e.g., Shatterproof Glass Corp. v. Libbey-Owens Ford Co., 758 F.2d 613, 619, 225 USPQ 634, 636 (Fed. Cir.), cert. dismissed, ___ U.S. ___, 106 S.Ct. 340, 88 L.Ed.2d 326 (1985); Railroad Dynamics, Inc. v. A. Stucki Co., 727 F.2d 1506, 1512, 220 USPQ 929, 936 (Fed. Cir.) cert. denied, 469 U.S. 871, 105 S.Ct. 220, 83 L.Ed.2d 150[114] (5) Patent Misuse
[115] Because no prior art anticipated the claims of the ‘586 patent, Safety’s assertion that Orthokinetics is guilty of patent misuse for asserting a patent, the ‘586 patent, that it knew was invalid under § 102(b), is without merit.
Page 1581
Palmer’s customer, unworthy of analysis and insufficient to overcome the jury’s finding (question no. 52) which the district court found to have been supported by substantial evidence. We agree.
[117] The district court correctly denied Safety’s motion for JNOV on patent misuse and Safety’s motion for a new trial on that issue.[118] (6) Conditional Grant of a New Trial
[119] This court must review a denial or grant of a motion for a new trial under an abuse of discretion standard. Medtronic, Inc. v. Intermedics, Inc., 799 F.2d 734, 740-41, 230 USPQ 641, 645 (Fed. Cir. 1986); Railroad Dynamics Inc., 727 F.2d at 1512, 220 USPQ at 935. “That question turns on whether an error occurred in the conduct of the trial that was so grievous as to have rendered the trial unfair.” DMI, Inc. v. Deere Co., 802 F.2d 421, 427, 231 USPQ 276, 280 (Fed. Cir. 1986); see Witco Chemical Corp. v. Peachtree Doors, Inc., 787 F.2d 1545, 1548, 229 USPQ 188, 190 (Fed. Cir.), cert. dismissed, ___ U.S. ___, 107 S.Ct. 258, 93 L.Ed.2d 241 (1986).
[122] The district court’s reasons for a new trial are based on a speculative and overly expansive view of the case law. Moreover, it does not point to any specific flaws in the instructions as given, or what different proposals, objections, and approach would have been taken or justified. [123] Regarding reason (1), the Sakamoto court held that “the disclosure prior to final argument of at least the substance of the Rule 49(a) special verdict interrogatories and supplemental instructions is mandatory.” 717 F.2d at 1006 (emphasis added). That court noted “that it may be an abuse of discretion to fail to show the Rule 49(a) interrogatories to counsel in advance of argument where, because of exceptional circumstances, such as the complexity of the case, unfairness would otherwise result.” However, the Sakamoto court determined that the appellant had shown no prejudice from the district court’s failure to disclose the additional interrogatory before the summation. Noting that counsel’s failure to object or request further argument, and everyone’s awareness of the issue represented by the additional interrogatory, established an absence of prejudice, the Sixth Circuit affirmed the district court’s denial of a new trial. [124] Whether the present case may be categorized as falling within Rule 49(a) or Rule 49(b), Sakamoto makes clear that Safety must show actual prejudice, which itHad counsel been aware that factual issues on validity were being submitted to the jury for binding verdicts, they might well have made different submissions, proposals and objections with respect to both the jury instructions and the special verdict. And had this Court been aware that the validity verdict would be binding, it certainly would have taken a different approach to the validity instructions and verdict.
Page 1582
failed to do. Safety knew what the issues were from the filing of the pretrial briefs onward and certainly when it assisted with the jointly-prepared jury instructions before closing argument. Moreover, like the appellant in Sakamoto, Safety made no objection and no request for further argument.
[125] Regarding reason (2), the district court determined tha Sakamoto “indicates that a general verdict included together with special verdict questions is impermissible, or at best null.” For the reasons set forth above, we do not read SakamotoPage 1583
court had made clear, before this trial, that jury verdicts in patent cases are binding. See White v. Jeffrey Mining Machinery Co., 723 F.2d 1553, 1558, 220 USPQ 703, 705 (Fed. Cir. 1983), cert. denied, 469 U.S. 825, 105 S.Ct. 104, 83 L.Ed.2d 49 (1984); Connell v. Sears, Roebuck Co., 722 F.2d 1542, 1547, 220 USPQ 193, 197-98 (Fed. Cir. 1983). Having failed to carry its burden before one jury, Safety has shown no such actual prejudice as would warrant a second chance before a second jury and the consequent doubling of the burden on Orthokinetics and the district court.
[132] The case was fully and fairly litigated, the instructions and interrogatories (to which Safety did not object) were jointly prepared and fully adequate to guide the jury in its consideration of the evidence presented. There exists no newly-discovered material evidence. A new trial would therefore be unwarranted. The district court’s conditional grant of a new trial was an abuse of discretion and must be vacated.[133] CONCLUSION
[134] The judgment entered in response to those of Safety’s motions for JNOV that were granted is reversed. The judgment entered on the jury verdict in light of the denial of Safety’s other motions for JNOV is affirmed. The district court’s denial of Safety’s motion for a new trial on infringement and misuse is affirmed. The district court’s conditional grant of a new trial on validity is vacated.
[137] APPENDIX[138] Question 2
[139] Do you find that Orthokinetics has proved by a preponderance of the evidence that defendant, Safety Travel Chairs, Inc., has directly infringed the following claims of the [‘586] patent by sale of Safety TranSporter Chair Models with adjustable scoliosis pads?
Page 1584
[158] Question 40Page 372
NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________…
NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________…
United States Court of Appeals for the Federal Circuit ______________________ CORE WIRELESS LICENSING S.A.R.L., Plaintiff-Appellee…
?United States Court of Appeals for the Federal Circuit ______________________ MAXLINEAR, INC., Appellant v. CF…
?United States Court of Appeals for the Federal Circuit ______________________ JASON CARL KENNEDY, Plaintiff-Appellant v.…
In re GPAC INC. No. 93-1216.United States Court of Appeals, Federal Circuit. Decided June 20,…